Last month, the FDA issued a final ruling on antibacterial soaps. No longer can manufacturers say these soaps are more effective than regular soap. Under the new rule, antibacterial soaps and body washes that contain certain chemicals cannot be marketed as such, simply because those ingredients didn’t prove to be both safe and effective for […]
Our pharmacists are truly indispensable. We thank you for all of your hard work, patience, and effort in making sure patients are adhering to their medications and are well-informed. In honor of National Pharmacy Week, we are celebrating YOU by launching a fun contest! One of the things that makes your job enjoyable is working in a great environment. […]
Pharmacists are an integral part of the healthcare system, and this month is dedicated to them. The goal of American Pharmacists Month is to promote the pharmacy profession, in an effort to help gain the attention you deserve from your patients, peers, and the community as a whole.
The Affordable Care Act (ACA) is one of those programs people either love or love to hate. Regardless of what side of the fence one comes down on, it has undeniably changed the landscape of healthcare since its inception in 2010. One of the recently documented benefits of the ACA is that more people are […]
A biosimilar is a biological medical product that is manufactured by a different company but almost identical to an original product. These are officially approved versions that are generally produced after the patent expires on the original product. These products are typically molecularly complex and manufacturing differences can be problematic. Because of the increased potential […]
September is National Recovery Month. Our Families, Our Stories, Our Recovery is the theme for 2016. The theme was chosen in order to focus on the valuable contribution families make to the recovery process. The Substance Abuse and Mental Health Services Administration provides many free resources for individuals and groups that wish to promote awareness […]
In July, the FDA approved the Repatha Pushtronex System. This is a single-dose delivery system that allows patients to receive 420 mg of the PCSK9 inhibitor in a single dose using SmartDose technology. The device should be available to consumers sometime in August.
In 2007, the FDA was tasked with developing a system for identifying and analyzing the risks associated with medical devices after they entered the market. The Sentinel Initiative was launched in 2008 in an effort to track the necessary information in a federal database. In February, the most advanced form of the Sentinel Initiative became […]
